-
Speeches in 2025 express exuberance for change and concern over same
Speakers emphasized technology‑neutral and principles‑based regulation, teased on new policies to come, or raised red flags.
-
Dana-Farber Cancer Institute pays $15m to resolve false claims charges
The case was exposed by an independent sleuth who used AI to uncover fraudulent, manipulated, and duplicated images.
-
A transformational 2025 in US healthcare – and more to come in 2026
In many ways, 2025 found the healthcare sector at a crossroads, with compliance officers holding their heads.
-
Illinois men face charges for $300m healthcare fraud scheme
The brothers allegedly tried to defraud Medicare, Medicaid, and private insurers by filing claims for COVID-19 testing that was never given.
-
Three faces of healthcare fraud: the billing practices that cost federal programs millions
Recent DOJ actions, including two Michigan pharmacy schemes and a nationwide wound care provider, show how different types of misconduct can thrive within the same reimbursement system.
-
Understanding FDA cybersecurity requirements for medical devices and FCA enforcement
Key considerations for medical device manufacturers and how to prepare for a cybersecurity incident.
-
CVS pays over $18m to settle federal and California FCA allegations
The settlement resolves claims from a former CVS pharmacist under federal FCA whistleblower provisions.
-
Patients Choice Laboratories pays over $9m to settle FCA allegations
The DOJ said the case demonstrates government emphasis on combating healthcare fraud, particularly through use of the FCA.